Vice-dean of Population Health and Health Inequities, UCSF School of Medicine
Chair and Professor, Department of Epidemiology and Biostatistics
Kirsten Bibbins-Domingo, PhD, MD, MAS is the Lee Goldman, MD Endowed Chair in Medicine. Bibbins-Domingo co-founded and currently directs the University of California, San Francisco (UCSF) Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital, a research center focused on discovery, implementation, policy, advocacy and community engagement for communities at risk for poor health and inadequate healthcare. She directs the CTSI Clinical and Translational Science Training Programs.
A general internist at Zuckerberg San Francisco General Hospital, Bibbins-Domingo has expertise in cardiovascular disease, diabetes and chronic kidney disease with a particular interest in the development of these diseases in young adults. Her work focuses on racial, ethnic and income differences in manifestations of chronic disease and effective clinical, public health and policy interventions aimed at prevention. She leads the UCSF Cardiovascular Disease Policy Model group. Dr. Bibbins-Domingo was a member of the US Preventive Services Task Force from 2010-2017 and is currently a consultant as the Immediate Past Chair.
Haile T. Debas
Haile T. Debas, MD, is recognized internationally for his contributions to academic medicine and is widely consulted on issues associated with global health. At UCSF, he served as Chair of the Department of Surgery, Dean of the School of Medicine, Vice Chancellor, Chancellor, and Founding Executive Director of Global Health Sciences (2003-2010). He is the Maurice Galante Distinguished Professor of Surgery, Emeritus at UCSF and Director Emeritus of the University of California Global Health Institute.
Dr. Debas was a lead editor of the Essential Surgery volume of Disease Control Priorities, Third Edition (DCP3) and co-authored the DCP3 chapter “Universal Health Coverage and Intersectoral Action for Health.”
Associate Professor of Medicine
Program Director, IGHS PhD in Global Health Sciences
Elizabeth Fair, PhD, MPH is an infectious disease epidemiologist with a primary appointment in the Department of Medicine, Division of Pulmonary and Critical Care Medicine and affiliated faculty appointments with the Institute for Global Health Sciences and the Curry International Tuberculosis Center. Dr. Fair’s research interests include tuberculosis (TB), TB/HIV, global health, and implementation/operational research. Her current work focuses on public health interventions for intensified TB case finding in high-burden settings.
Dr. Fair has worked since 2009 with the National Tuberculosis and Leprosy Program (NTLP) and National Institute of Medical Research (NIMR) in Tanzania to design and implement TB contact investigation under program conditions, and to evaluate the feasibility, yield, and cost-effectiveness of TB contact investigation in Dar es Salaam. Findings from this project led to implementation of TB contact investigation in Iringa, a rural district of Tanzania, as well as plans for scaling-up TB contact investigation within the NTLP in Dar es Salaam. She also piloted home-based HIV testing during TB contact investigation.
She currently is working on projects exploring TB stigma in Bangladesh and is co-Investigator on an R01 grant investigating the use of mobile health for implementation of TB contact investigation in Kampala, Uganda. Dr. Fair serves as a regular consultant for the American Thoracic Society (ATS), World Health Organization (WHO), and the Dutch Tuberculosis Group (KNCV). She serves on WHO Steering Committees to develop new policies related to TB case finding and TB international standards of care (ISTC), and through the USAID funded CHALLENGE TB mechanism provides technical assistance for Indonesia, Tanzania, and Mozambique.
Sir Richard Feachem
Director, Global Health Group
Professor Sir Richard Feachem, KBE, BSc, PhD, DSc(Med), is director of the Global Health Group at UCSF Institute for Global Health Sciences and professor of Global Health at both UCSF and UC Berkeley. He is also a Visiting Professor at London University and an Honorary Professor at the University of Queensland.
From 2002 to 2007, Feachem served as founding executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria and under-secretary general of the United Nations. From 1995 until 1999, Feachem was director for Health, Nutrition and Population at the World Bank. Previously (1989-1995), he was dean of the London School of Hygiene and Tropical Medicine.
Feachem served as Chairman of the Foundation Council of the Global Forum for Health Research; Treasurer of the International AIDS Vaccine Initiative; Council Member of Voluntary Service Overseas; and on numerous other boards and committees. He was a member of the Commission on Macroeconomics and Health, the Commission on HIV and Governance in Africa, and the Commission on Investing in Health. He has published extensively on epidemiology, public health and health policy.
Harvey V. Fineberg
President, Gordon and Betty Moore Foundation
Harvey V. Fineberg, MD, PhD, is the president of the Gordon and Betty Moore Foundation. He previously held the Presidential Chair at UCSF. Prior to that, he served as president of the Institute of Medicine from 2002 to 2014 and as provost of Harvard University from 1997 to 2001, following 13 years as dean of the Harvard School of Public Health. He has devoted most of his academic career to the fields of health policy and medical decision-making. His past research has focused on the process of policy development and implementation, assessment of medical technology, evaluation and use of vaccines, and dissemination of medical innovations.
Fineberg chairs the board of the Carnegie Endowment for International Peace and serves on the boards of the William and Flora Hewlett Foundation and the China Medical Board. He helped found and served as president of the Society for Medical Decision Making and also served as consultant to the World Health Organization.
Fineberg is co-author of the books Clinical Decision Analysis, Innovators in Physician Education and The Epidemic That Never Was, an analysis of the controversial federal immunization program against swine flu in 1976. He has co-edited several books on such diverse topics as AIDS prevention, vaccine safety, understanding risk in society and global health.
UN Special Envoy on Tuberculosis
Director, Center for Global Health Delivery and Diplomacy
Eric Goosby, MD, is a professor of medicine and director of Center for Global Health Delivery and Diplomacy, Institute for Global Health Sciences, at UCSF. In January 2015, Dr. Goosby was appointed by UN Secretary-General Ban Ki-moon to be the UN Special Envoy on Tuberculosis (TB). As Special Envoy, he works to promote awareness of TB, both to encourage people to get tested and to send a message to world leaders that more resources are needed to make the world free from TB.
From 2009-2013, he served in the Obama Administration as Ambassador-at-Large and U.S. Global AIDS Coordinator, overseeing the implementation of the President’s Emergency Plan for AIDS Relief (PEPFAR), and also led the State Department’s Office of Global Health Diplomacy.
As CEO and Chief Medical Officer of Pangaea Global AIDS Foundation, 2001-2009, he played a key role in the development and implementation of HIV/AIDS national treatment scale-up plans in South Africa, Rwanda, China and Ukraine.
During the Clinton Administration, Dr. Goosby was Director of the Ryan White Care Act at the U.S. Department of Health and Human Services (HHS), and later, served as Deputy Director of the White House National AIDS Policy Office and Director of the Office of HIV/AIDS Policy at HHS.
Professor of Emergency Medicine
Renee Y. Hsia, M.D., M.Sc. is a professor and director of Health Policy Studies in the Department of Emergency Medicine at UCSF, and director of The PLACE (The Policy Lab for Acute Care and Emergencies). She is also a core faculty member of the UCSF Philip R. Lee Institute for Health Policy Studies (IHPS), as well as a member of the UCSF Center for Healthcare Value and the UCSF Global Health Economics Consortium. Dr. Hsia provides emergency care at the Zuckerberg San Francisco General Hospital & Trauma Center.
Dr. Hsia’s broad research interests are in health services issues related to increasing access to emergency care and regionalization of care. She studies population access to emergency departments and trauma centers in the U.S; the distribution of emergency care across income areas; factors associated with closure of emergency services (both emergency departments and trauma centers); how these closures affect patient outcomes, specifically focusing on patients with acute myocardial infarction, stroke, asthma/COPD, sepsis and trauma; and the variation of costs and charges in the healthcare system. Her research program also focuses on healthcare costs and financing issues with regard to emergency care. She is also the site PI for several multi-site studies validating trauma triage criteria for different age groups as well as their ability to predict high-risk patients. She has published on these issues in a broad range of journals, and her research has been widely publicized in print and broadcast media. Dr. Hsia hopes that this work will help to inform policymakers on the monitoring and oversight of the equitable provision of critical services to patients across the country, and overall improvement of the system's ability to deliver healthcare.
UCSF Professor Emeritus
Series Editor, Disease Control Priorities, Third Edition
Dean T. Jamison, PhD, led work on the nine-volume Disease Control Priorities series from the World Bank and was lead author of the synthesizing publication (The Lancet, December 2017). He also served as co-editor of DCP3’s volumes on Essential Surgery, Child and Adolescent Health and Development and Disease Control Priorities.
He is emeritus professor in the Institute for Global Health Sciences at UCSF. In addition to UCSF, Jamison has been with UCLA and University of Washington and has served as the T. & G. Angelopoulos Visiting Professor in the Harvard Kennedy School and the Harvard School of Public Health (2006-2008). HE previously worked at the World Bank as an economist and as a manager, and was lead author for the Bank’s 1993 World Development Report, Investing in Health. Jamison served as co-chair with Lawrence H. Summers of The Lancet Commission on Investing in Health (The Lancet, December 2013).
Director, Center for Global Surgical Studies
Catherine Juillard, M.D., M.P.H. is a general surgeon with clinical interests in general surgery, trauma and surgical critical care. Dr. Juillard obtained a Bachelor of Arts from Stanford University and her M.D. degree from the University of California, Los Angeles. During her surgical residency training at the University of California, Los Angeles, Dr. Juillard received her M.P.H. degree from the Johns Hopkins School of Public Health and was a post-doctoral fellow with the Johns Hopkins International Injury Research Unit. After completing her General Surgery residency, she completed a fellowship in Trauma/Critical Care at the University of California, San Francisco. Dr. Juillard has strong interest in global surgery research and was recently named director of the UCSF Center for Global Surgical Studies.
Assistant Professor of Medicine
Carina Marquez, MD, is an assistant professor of Medicine and associate director of Education in the Division of HIV, Infectious Diseases, and Global Medicine at Zuckerberg San Francisco General Hospital (ZSFG). Her research focuses on elucidating the drivers of the large latent TB reservoir in East Africa and developing interventions to prevent TB infection and to improve the TB care continuum for HIV-infected and uninfected children and adults living in sub-Saharan Africa. She is the co-chair of HIV Grand Rounds, the Assistant Director of the Infectious Diseases Clinic at ZSFG, and directs the SALUD clinic, a clinic within the Positive Health Practice "Ward 86" at ZSFG, that is dedicated to providing multidisciplinary care to monolingual Spanish-speaking HIV-infected patients.
Professor of Medicine Emeritus
Mike McCune, MD, PhD, began treating patients with HIV disease as a resident in internal medicine at UCSF in 1982 and has been involved in the HIV/AIDS research field ever since. This work included postdoctoral studies at Stanford, exploring the fusogenic properties of the HIV envelope protein and developing the first humanized mouse model (the SCID-hu mouse) capable of multi-lineage human hematopoiesis and receptive to infection with primary isolates of HIV. He then co-founded the companies SyStemix (in 1988) and Progenesys (and 1991), serving as Scientific Director and leading research efforts to find better ways – including antiviral medications and hematopoietic stem cell-based gene therapy – to treat HIV disease. In 1995, Dr. McCune returned to academia, first as an investigator at the Gladstone Institute of Virology and Immunology and then (from 2006-2016) as the Chief of the Division of Experimental Medicine, which he founded, at UCSF. He also was the founding PI and Senior Associate Dean of the Clinical and Translational Sciences Institute at UCSF (from 2005-08). In recent years, he has helped to form multidisciplinary, collaborative research teams to find a cure for HIV disease.
Associate Professor of Psychiatry
Susan M. Meffert M.D., M.P.H. is an associate professor in the UCSF Department of Psychiatry and is a UCSF Institute for Global Health Sciences Faculty Affiliate.
Dr. Meffert is interested in how violence and trauma replicate across survivors’ lives, families and communities by creating emotional disorders that impact interpersonal relationships and put close contacts at risk of mental health disorders. She completed a successful pilot RCT of Interpersonal Psychotherapy (IPT) for depression and Posttraumatic Stress (PTSD) symptoms among Darfur refugees in Cairo with treatment delivered by community members and an RCT of IPT in China with survivors of the Sichuan earthquake in which treatment is delivered by local paraprofessionals.
Through her research, Dr. Meffert became interested in the strong associations between violence, trauma and HIV among women in low resource settings. Her current work focuses on HIV+ women exposed to gender-based violence (GBV) in sub-Saharan Africa, where 75% of the world's HIV+ women live. Dr. Meffert collaborates with the UCSF Family AIDS Care and Education Services (FACES) PEPFAR-funded program based in Kisumu, Kenya, where she has used qualitative methods to assess mental health trauma care needs among HIV+ women affected by GBV and is now running a T2 level effectiveness-implementation hybrid study to evaluate clinical and implementation parameters of non-specialist delivery of IPT for HIV+GBV+ women served by FACES delivered in an integrated manner within the HIV clinic.
Professor of Medicine
Payam Nahid, MD, MPH, conducts clinical trials and translational research in TB with the goal of improving the care of patients with TB and HIV/TB worldwide. His research is conducted both in the United States and internationally, specifically in Hanoi and Ho Chi Minh City, Vietnam. The research team in Vietnam conducts field studies of new TB diagnostics, Phase 2 and 3 clinical trials in TB therapeutics (as part of the CDC-TB Trials Consortium) and latent TB infection treatment implementation studies, in close partnership with the Vietnam National TB Program, the Vietnam National Lung Hospital, the Hanoi Lung Hospital, Cho Ray Hospital and the Vietnam National Institute of Hygiene and Epidemiology.
Nahid is protocol co-chair of an international, FDA-registration trial evaluating daily, high dose rifapentine-based shortened regimens for drug susceptible TB. He also serves on the WHO Task Force on the Development of Policies for Introduction of New TB Drugs and Treatment Regimens. With funding from NIH NIAID and in collaboration with bench and translational scientists, he leads TB biomarker discovery and qualification programs to identify improved biomarkers of treatment effect. He maintains an active academic clinical practice and attends at the Chest Clinic at Zuckerberg San Francisco General Hospital, on the inpatient pulmonary service, the medical intensive care unit and at the SFDPH TB Control Clinic. Nahid also provides clinical TB consultation and training as part of the UCSF Curry International Tuberculosis Center, and has contributed to the development of U.S. and international practice guidelines for the treatment of TB.
President, QURE Healthcare LLC
Professor of Epidemiology and Biostatistics
John Peabody, MD, PhD, started his career in developing countries, working for the World Health Organization and on behalf of the World Bank. During his 20-years academic career with UCLA and UCSF, he has focused on highlighting the incredible and often dangerous variation in clinical practice, which his work has shown to be ubiquitous in both low- and high-income countries. Peabody’s insights led to the development of an on-line practice variation measurement tool—Clinical Performance and Value (CPV) simulations, which are now used by providers across the world in all types of health care systems and in biotechnology to generate clinical utility data, for all types of clinical conditions. CPVs quickly and affordably measure and re-measure practice variation. In 2012, he started QURE Healthcare LLC, to meet the demand among health systems for a proven solution to engage physicians, improve practice and lower costs. Today more than 10,000 providers have gone through the QURE approach and QURE’s scalable solution can generate tens of millions of dollars in lower costs for patients, providers and payers around the world.
Peabody has also served as a senior fellow at Sg2 , a senior researcher at RAND and as an executive of the biotech company Amgen. He currently serves as a senior advisor to Autism Speaks and regularly advises the World Bank, the Gates Foundation and the WHO.
Deputy Director, UCSF Malaria Elimination Initiative
Allison Phillips, BA, is the deputy director of the Global Health Group’s Malaria Elimination Initiative (MEI) in the UCSF Institute for Global Health Sciences and a founding team member of the MEI, having joined the project in 2008. Phillips co-leads the MEI’s strategy, fundraising efforts, grant management, donor and partner relations and team operations. She has a strong interest in securing an enabling environment for countries and regional initiatives to successfully eliminate malaria and prevent reintroduction.
Prior to joining the MEI, Phillips worked in Tanzania for three years with a large NGO to lead malaria and HIV prevention education programs in rural farming communities and in small/medium-sized workplaces. She also worked with McKinsey & Company to recommend investment opportunities in the private health sector across Africa, worked on HIV/AIDS in Thailand, and researched the relationship between modern and traditional medicine in India.
Executive Director, UCSF Institute for Global Health Sciences
Jaime Sepulveda, MD, DSc, MPH, the Haile T. Debas Distinguished Professor of Global Health, is the Executive Director of UCSF Institute for Global Health Sciences. A member of the Chancellor’s Cabinet, he leads a team of more than 300 faculty and staff engaged in translating UCSF’s scientific leadership into programs that positively impact health and reduce inequities globally. Sepulveda oversees several education and training programs, including the Master of Science in Global Health, the first such program in the nation, and the PhD in Global Health Sciences.
From 2007 to 2011, Sepulveda was a member of the Foundation Leadership Team at the Bill & Melinda Gates Foundation and served as director of Integrated Health Solutions, director of Special Initiatives and senior fellow in the Global Health Program. He also played a central role in shaping the foundation’s overall global health strategy as part of its executive team and worked closely with key foundation partners to increase access to vaccines and other effective health solutions in developing countries.
Sepulveda worked for more than 20 years in a variety of senior health posts in the Mexican government including Director-General of Epidemiology, Vice-Minister of Health, and Director of the National Institutes of Health of Mexico. For almost a decade, he served as Director-General of Mexico’s National Institute of Public Health and Dean of the National School of Public Health. Sepulveda designed Mexico’s Universal Vaccination Program, achieving universal childhood immunization coverage. He also founded Mexico’s National AIDS Council, in the 1980’s, which helped to contain early on the spread of the HIV epidemic.
Dana van Gorder
Executive Director, Project Inform
Dana van Gorder is the executive director of Project Inform, a national non-profit agency assisting in the development of treatments for HIV infection, providing treatment information to HIV-positive individuals, engaging in advocacy to meet the health care needs of low-income HIV-positive people, and advocating for biomedical prevention strategies. In this role, he has helped to lead national efforts to assure implementation of HIV treatment as prevention through his work as a member of the Steering Committee for a National HIV/AIDS Strategy. He is also working to support the implementation of Pre-Exposure Prophylaxis(PrEP) for gay and bisexual men as a member of the National PrEP Working Group.
From 2000 to 2008, van Gorder served as the director of State & Local Policy for the San Francisco AIDS Foundation. In that role, he developed and monitored legislation and advocated for funding to assure the highest possible response to the epidemic in California. He also secured $10 million in funding for a statewide campaign to prevent methamphetamine abuse among gay and bisexual men. Van Gorder served as the coordinator of Lesbian & Gay Health Services for the San Francisco Department of Public Health from 1995 to 2000. During that time, he was extensively involved in research and writing regarding psychosocial determinants of risky sexual behavior among gay and bisexual men and lead the first efforts to address rising levels of methamphetamine use in this community.
Director, AIDS Research Institute
Paul Volberding, MD, is a professor of medicine at UCSF, director of the AIDS Research Institute and co-director of the UCSF-GIVI Center for AIDS Research. For 20 years, Dr. Volberding's professional activities centered at San Francisco General Hospital, where he established a model program of AIDS care, research and professional education. His research career began with investigations of HIV-related malignancies but shifted to clinical trials of antiretroviral drugs. He helped lead early studies in asymptomatic infection that led to the concept of HIV disease as the target of treatment. He more recently served as the Chief of Medicine at the San Francisco VA Medical Center. Dr. He is the co-editor-in-chief of the Journal of Acquired Immune Deficiency Syndrome (JAIDS). He has written several textbooks including Sande’s HIV/AIDS Medicine and the companion text, Global Care, specifically for use in resource limited settings. He is the founder and chair of the board of the International Antiviral Society-USA and a past president of the HIV Medical Association of the Infectious Diseases Society of America.